A phase I study of Onyx-015, an ELB-attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000)

Ganly, I Kirn, D Eckhardt, SG Rodriguez, GI Soutar, DS Otto, R Robertson, AG Park, O Gulley, ML Heise, C VonHoff, DD Kaye, SB

I. Ganly et al., A phase I study of Onyx-015, an ELB-attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000), CLIN CANC R, 7(3), 2001, pp. 754-754

1

Oncology

CLINICAL CANCER RESEARCH

10780432 → ACNP

7

3

2001

754 - 754

ISI

1078-0432(200103)7:3<754:APISOO>2.0.ZU;2-I